Ophthotech $OPHT Licenses Rights to Develop AAV Gene Therapies for Best Disease from Penn uflorida httpow.lyW2yU30optJ5Âpic.twitter.comGLGyhxHGmW
Ophthotech ($OPHT) Licenses Rights to Develop AAV Gene Therapies for Best Disease from @Penn, @uflorida: http://ow.ly/W2yU30optJ5 pic.twitter.com/GLGyhxHGmW
More From BioPortfolio on "Ophthotech ($OPHT) Licenses Rights to Develop AAV Gene Therapies for Best Disease from @Penn, @uflorida: http://ow.ly/W2yU30optJ5 pic.twitter.com/GLGyhxHGmW"